Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG37256

GPR107 Knockout Hela Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Uterus (cervix)

  • Disease:

    Adenocarcinoma

The GPR107 Knockout HeLa Polyclonal Cells provide a CRISPR/Cas9-edited polyclonal population of HeLa cells with disrupted GPR107, an orphan GPCR essential for Hedgehog signaling. This loss-of-function model allows investigation of GPR107-mediated regulation of SMO trafficking and GLI-dependent transcription, in a widely used cervical adenocarcinoma background. Applications include analysis of Hedgehog target genes such as GLI1 and PTCH1, protein interaction studies with PRKACA, and cell-based assays for pathway activity. The model supports cancer biology and developmental signaling research, providing a versatile tool for mechanistic and pharmacological studies.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HeLa

    Sex of Donor

    Female

    Age

    31 years

    Gene Name

    GPR107

    Gene Identifier

    NCBI Gene ID 57720

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM (with NEAA)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The GPR107 Knockout HeLa Polyclonal Cells product consists of a CRISPR/Cas9-edited polyclonal population of HeLa cells carrying targeted disruption of the GPR107 gene. This loss-of-function model enables the study of orphan G protein-coupled receptor 107 function within a defined host background. The polyclonal knockout format provides a heterogeneous gene-edited population suitable for pooled functional experiments and pathway analysis, without clonal selection artifacts.

HeLa cells, a human epithelial cell line originally isolated from a cervical adenocarcinoma, serve as a widely used model for human cell biology, cancer research, and signal transduction studies. These adherent cells exhibit rapid proliferation and a well-characterized genome, facilitating reliable interpretation of genetic perturbations. The HeLa background endogenously expresses core Hedgehog pathway components and supports high transfection efficiency, making it a robust platform for GPR107 knockout experiments.

GPR107 encodes an orphan G protein-coupled receptor that is indispensable for Hedgehog signaling. Mechanistically, it interacts with Smoothened (SMO) and recruits the catalytic subunit of PKA (PRKACA) to regulate SMO trafficking and GLI activation. Following SHH ligand binding, GPR107 relieves SUFU-dependent repression of GLI transcription factors, promoting expression of downstream effectors such as GLI1, PTCH1, and HHIP. Additionally, GPR107 associates with GNAS, integrating Hedgehog signals with cAMP/PKA cascades.

Disruption of GPR107 in HeLa cells abrogates Hedgehog pathway responsiveness, creating a powerful model to dissect GPCR-mediated signal transduction in an epithelial cancer context. Given the role of aberrant Hedgehog signaling in tumorigenesis and neural tube defects, this knockout system enables investigation of pathway dependencies, proliferation control, and oncogenic mechanisms. The HeLa cervical cancer origin provides a relevant background to assess the interplay between GPR107 loss and tumor cell behavior.

This polyclonal knockout population is suitable for qPCR analysis of Hedgehog target genes, Western blotting of SMO and GLI, luciferase reporter assays, and SMO localization studies by immunofluorescence. Co-immunoprecipitation can confirm GPR107-PKA complexes, and cell proliferation assays can evaluate Hedgehog-dependent growth. The model is ideal for pharmacological inhibitor screening and genetic interaction studies. For additional information, contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)